A detailed history of Heartland Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Heartland Bank & Trust CO holds 8,580 shares of ABBV stock, worth $1.51 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
8,580
Previous 8,725 1.66%
Holding current value
$1.51 Million
Previous $1.5 Million 13.24%
% of portfolio
0.92%
Previous 0.85%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $23,756 - $28,902
-145 Reduced 1.66%
8,580 $1.69 Million
Q2 2024

Aug 21, 2024

BUY
$154.79 - $180.76 $374,746 - $437,619
2,421 Added 38.4%
8,725 $1.5 Million
Q1 2024

May 17, 2024

SELL
$159.82 - $182.1 $6,872 - $7,830
-43 Reduced 0.68%
6,304 $1.15 Million
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $30,822 - $34,713
224 Added 3.66%
6,347 $983,000
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $8,950 - $10,361
67 Added 1.11%
6,123 $912,000
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $54,329 - $67,609
410 Added 7.26%
6,056 $815,000
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $556,893 - $641,345
-3,851 Reduced 40.55%
5,646 $899,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $69,431 - $83,266
-502 Reduced 5.02%
9,497 $1.54 Million
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $196,349 - $225,199
1,463 Added 17.14%
9,999 $1.34 Million
Q2 2022

Jul 12, 2022

BUY
$137.62 - $174.96 $12,798 - $16,271
93 Added 1.1%
8,536 $1.31 Million
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $757,565 - $939,925
5,740 Added 212.36%
8,443 $1.37 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $290,383 - $367,418
2,703 New
2,703 $366,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Heartland Bank & Trust CO Portfolio

Follow Heartland Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Bank & Trust CO with notifications on news.